Hyperbaric oxygen treatment attenuates the pro-inflammatory and immune responses in apolipoprotein E knockout mice

Clinical Immunology

Volumn 128, Issue 3, 2008, Pages 435-441

  Kudchodkar, Bhalchandra ^a   Jones, Harlan ^a   Simecka, Jerry ^a   Dory, Ladislav ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

ApoE KO mice; Atherosclerosis; Auto antibodies; Delayed type hypersensitivity response; Hyperbaric oxygen; Immune response; Pro and anti inflammatory cytokines

Indexed keywords

APOLIPOPROTEIN E; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; ATHEROSCLEROSIS; B LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; FEMALE; HUMORAL IMMUNITY; HYPERBARIC OXYGEN; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY DISEASE; KNOCKOUT MOUSE; LIPID BLOOD LEVEL; MONONUCLEAR CELL; MOUSE; NONHUMAN; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; RABBIT; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

ANIMALS; APOLIPOPROTEINS E; AUTOANTIBODIES; CYTOKINES; FEMALE; HYPERBARIC OXYGENATION; HYPERSENSITIVITY, DELAYED; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; LIPOPROTEINS, LDL; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; SPLEEN; T-LYMPHOCYTES;

EID: 49149093715     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.05.004     Document Type: Article

References (33)

1. Ross R. Atherosclerosis - an inflammatory disease. New Eng. J. Med. 340 (1999) 115-126
2. Wung B.S., Cheng J.J., Hsieh H.J., Shyy Y.J., and Wang D.L. Cyclic strain-induced monocyte chemotactic protein-1 gene expression in endothelial cells involves reactive oxygen species activation of activator protein-1. Circ. Res. 81 (1997) 1-7
3. Kunsch C., and Medford R.M. Oxidative stress as a regulator of gene expression in the vasculature. Circ. Res. 85 (1999) 753-766
4. Tontonoz P., Nagy L., Alvarez J.G.A., Thomazy V.A., and Evans R.M. PPAR gamma promotes monocyte/macrophage activation and uptake of oxidized LDL. Cell 93 (1988) 241-252
5. Kudchodkar B.J., Wilson J., Lacko A., and Dory L. Hyperbaric oxygen reduces the progression and accelerates the regression of atherosclerosis in rabbits. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1637-1643
6. Kudchodkar B.J., Pierce A., and Dory L. Chronic hyperbaric oxygen treatment elicits an anti oxidant response and attenuates atherosclerosis in apoE knockout mice. Atherosclerosis 193 (2007) 28-35
7. Sakashita Y., Hiyama E., Imamura Y., Sugahara Y., Takesue Y., Matsuura Y., and Yokoyama T. Generation of pro-inflammatory and anti-inflammatory cytokines in the gut in zymosan-induced peritonitis. Hiroshima J. Med. Sci. 49 (2000) 43-48
8. Lugano C., Imperatore F., Cuzzocrea S., Filippelli A., Scafuro A., Mangoni G., Portolano F., and Rossi F. Effects of hyperbaric oxygen exposure on zymosan-induced shock model. Crit. Care Med. 26 (1998) 1972-1976
9. Chen M.F., Chen H.M., Ueng S.W., and Shyr M.H. Hyperbaric oxygen treatment attenuates hepatic reperfusion injury. Liver 18 (1998) 110-116
10. Saito K., Tanaka Y., Ota T., Eto S., and Yamashita U. Suppressive effect of hyperbaric oxygenation on immune responses of normal and autoimmune mice. Clin. Exp. Immunol. 86 (1991) 322-327
11. Xu X., Yi H., Kato M., Suzuki H., Kobayashi S., Takahashi H., and Nakashima I. Differential sensitivities to hyperbaric oxygen of lymphocyte subpopulations of normal and autoimmune mice. Immunol. Lett. 59 (1997) 79-84
12. Hansbrough J.F., Piacentine J.G., and Eiseman B. Immunosupression by hyperbaric oxygen. Surgery 87 (1980) 662-667
13. Erdmann D., Roth A.C., Hussmann J., Lyons S.F., Mody N.J., Kukan J.O., and Russel R.C. Skin allograft rejection and hyperbaric oxygen treatment in immune-histoincompatible mice. Undersea Hyperb. Med. 22 (1995) 395-399
14. + regulatory T cells in hyperbaric oxygen-mediated immune nonresponsiveness. Hum. Immunol. 61 (2000) 1320-1331
15. Hansson G.K., Libby P., Schonbeck U., and Yan Z.Q. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ. Res. 91 (2002) 281-291
16. Huber S.A., Sakkinen P., David C., Newell M.K., and Tracy R.P. T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia. Circulation 103 (2001) 2610-2621
17. Tedgui A., and Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol. Rev. 86 (2006) 515-581
18. Phanupak P., Moorhead J.W., and Claman H.N. Tolerance and contact sensitivity to DNFB in mice. J. Immunol. 112 (1974) 115-123
19. Simecka J.W., Patel P., and Kern E.R. Immunotoxic potential of antiviral drugs: effects of gancyclovir and (S)-1-(3-hydroxy-2-phosphonylmethoxy propyl) cytosine on lymphocyte transformation and delayed-type hypersensitivity responses. Antiviral Res. 18 (1992) 53-64
20. Kruisbeek A. In: Coligan J.E., Kruisbeek A., Margulies D., Shevac E., and Strober W. (Eds). Isolation and fractionation of mononuclear cell populations. Current Protocols in Immunology vol. 1 (1999), John Wiley & Sons, New York 3.1.1.
21. Jones H., Hodge L., Fujihashi K., Kiyono H., McGhee J.R., and Simecka J.W. The pulmonary environment promotes Th2 cell responses after nasal-pulmonary immunization with antigen alone, but Th1 responses are induced during instances of intense immune stimulation. J. Immunol. 167 (2001) 4518-4526
22. Tsimikas S., Palinski W., and Witztum J.L. Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 95-100
23. Getz G.S. Immune function in atherogenesis. J. Lipid Res. 46 (2005) 1-10
24. Chen S.Y., Chen Y.C., Wang J.K., Hsu H.P., Ho P.S., Chen Y.C., and Sytwu H.K. Early hyperbaric oxygen therapy attenuates disease severity in lupus-prone autoimmune (NZB X NZW) F1 mice. Clin. Immunol. 108 (2003) 103-110
25. Warren J., Sackstedler R., and Thuning C.A. Oxygen immunosupression: modification of experimental allergic encephalomyelitis in rodents. J. Immunol. 121 (1978) 315-320
26. Sumen G., Cimsit M., and Eroglu L. Hyperbaric oxygen treatment reduces carrageenan-induced acute inflammation in the rat. Eur. J. Pharmacol. 431 (2001) 265-268
27. Gupta S., Pablo A.M., Jiang X.C., Wang N., Tall A.R., and Schindler C. IFN-gamma potentiates atherosclerosis in apoE knock-out mice. J. Clin. Invest. 99 (1997) 2752-2761
28. Lee T.Z., Yen H.C., Pan C.C., and Chau L.Y. The role of interleukin 12 in the development of atherosclerosis in apoE deficient mice. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 734-742
29. Mallet Z., Besnard S., Duriez M., Deleuze V., Emmanuel F., Bureau M.F., Soubrier F., Esposito E., Duez F., Fievet C., Stales B., Duverger N., Scherman D., and Tedgui A. Protective role of interleukin 10 in atherosclerosis. Circ. Res. 85 (1999) e17-e24
30. Pinderski L.J., Fischbein M.P., Subbanagounder G., Fischbein M.C., Kubo N., Cheroutre H., Curtiss L.K., Berliner J.A., and Boisvert W.A. Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes. Circ. Res. 90 (2002) 1064-1071
31. Kuga S., Otsuka T., Niiro H., Nunoi H., Nemoto Y., Nakano T., Ogo T., Umei T., and Niho Y. Suppression of superoxide anion production by interleukin-10 is accompanied by downregulation of genes for subunit proteins of NADPH oxidase. Exp. Hematol. 24 (1996) 151-157
32. de Vries J.E. Immunosuppressive and anti-inflammatory properties of IL-10. Ann. Med. 27 (1995) 537-541
33. Enk A.H., Angeloni V.L., Udey M.C., and Katz S.I. Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. J. Immunol. 151 (1993) 2390-2398